Skip to main content

Animations

MJFF Publications

2051 - 2060 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • 2024
  • 2022
  • 2023
  • 2024
  • Summary Details
    OPEN
    Title: OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBE
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.914486
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.15307
    Citation Count: 102
  • Summary Details
    OPEN
    Title: Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo‐Controlled Trial of Rasagiline
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28838
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-022-00674-x
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progression
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.977985
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00366-z
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances
    Journal Name: BMC Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s12916-024-03766-5
    Citation Count: 1
  • Summary Details
    OPEN
    Title: It Is as It Was: MDS‐UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29279
    Citation Count: 14
  • Summary Details
    OPEN
    Title: In vivoreduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awac445
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00819-7
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.